Measuring the costs of nosocomial infections: Methods for estimating economic burden on the hospital

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

To compete more effectively for resources, it is increasingly important for infection control practitioners to estimate the costs of nosocomial infections and the amount of money their infection control programs save the hospital. Studies on costs should estimate both extra length of stay and extra costs attributable to infectious complications. Cost estimates should either adjust charges by a cost to charge ratio, which is relatively easy, or estimate hospital costs directly by detailed cost-accounting, which is comparatively more difficult. If there is insufficient time to measure costs concurrently in every infected patient, comparative studies can be done by comparing infected and uninfected patients matched on characteristics that control for the preexisting differences between them. Diagnosis-related groups and the number of diagnoses appear to be useful matching variables because they are strongly associated with both nosocomial infection and length of stay. The final results should be expressed as either potential or actual savings to the hospital, depending on whether significant reductions in nosocomial infection rates have been achieved.

Original languageEnglish (US)
JournalThe American journal of medicine
Volume91
Issue number3 SUPPL. 2
DOIs
StatePublished - Sep 16 1991

Fingerprint

Cross Infection
Economics
Costs and Cost Analysis
Length of Stay
Infection Control Practitioners
Hospital Costs
Diagnosis-Related Groups
Infection Control

ASJC Scopus subject areas

  • Nursing(all)

Cite this

@article{345fe38c640041bcbbe0d2ffd9203ef1,
title = "Measuring the costs of nosocomial infections: Methods for estimating economic burden on the hospital",
abstract = "To compete more effectively for resources, it is increasingly important for infection control practitioners to estimate the costs of nosocomial infections and the amount of money their infection control programs save the hospital. Studies on costs should estimate both extra length of stay and extra costs attributable to infectious complications. Cost estimates should either adjust charges by a cost to charge ratio, which is relatively easy, or estimate hospital costs directly by detailed cost-accounting, which is comparatively more difficult. If there is insufficient time to measure costs concurrently in every infected patient, comparative studies can be done by comparing infected and uninfected patients matched on characteristics that control for the preexisting differences between them. Diagnosis-related groups and the number of diagnoses appear to be useful matching variables because they are strongly associated with both nosocomial infection and length of stay. The final results should be expressed as either potential or actual savings to the hospital, depending on whether significant reductions in nosocomial infection rates have been achieved.",
author = "Haley, {Robert W.}",
year = "1991",
month = "9",
day = "16",
doi = "10.1016/0002-9343(91)90341-T",
language = "English (US)",
volume = "91",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "3 SUPPL. 2",

}

TY - JOUR

T1 - Measuring the costs of nosocomial infections

T2 - Methods for estimating economic burden on the hospital

AU - Haley, Robert W.

PY - 1991/9/16

Y1 - 1991/9/16

N2 - To compete more effectively for resources, it is increasingly important for infection control practitioners to estimate the costs of nosocomial infections and the amount of money their infection control programs save the hospital. Studies on costs should estimate both extra length of stay and extra costs attributable to infectious complications. Cost estimates should either adjust charges by a cost to charge ratio, which is relatively easy, or estimate hospital costs directly by detailed cost-accounting, which is comparatively more difficult. If there is insufficient time to measure costs concurrently in every infected patient, comparative studies can be done by comparing infected and uninfected patients matched on characteristics that control for the preexisting differences between them. Diagnosis-related groups and the number of diagnoses appear to be useful matching variables because they are strongly associated with both nosocomial infection and length of stay. The final results should be expressed as either potential or actual savings to the hospital, depending on whether significant reductions in nosocomial infection rates have been achieved.

AB - To compete more effectively for resources, it is increasingly important for infection control practitioners to estimate the costs of nosocomial infections and the amount of money their infection control programs save the hospital. Studies on costs should estimate both extra length of stay and extra costs attributable to infectious complications. Cost estimates should either adjust charges by a cost to charge ratio, which is relatively easy, or estimate hospital costs directly by detailed cost-accounting, which is comparatively more difficult. If there is insufficient time to measure costs concurrently in every infected patient, comparative studies can be done by comparing infected and uninfected patients matched on characteristics that control for the preexisting differences between them. Diagnosis-related groups and the number of diagnoses appear to be useful matching variables because they are strongly associated with both nosocomial infection and length of stay. The final results should be expressed as either potential or actual savings to the hospital, depending on whether significant reductions in nosocomial infection rates have been achieved.

UR - http://www.scopus.com/inward/record.url?scp=14044251572&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14044251572&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(91)90341-T

DO - 10.1016/0002-9343(91)90341-T

M3 - Article

C2 - 1928186

AN - SCOPUS:14044251572

VL - 91

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 3 SUPPL. 2

ER -